XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Series B Convertible Preferred Stock
Preferred Stock
6% Convertible Exchangeable Preferred Stock
Preferred Stock
Common Stock
Series B Convertible Preferred Stock
Common Stock
6% Convertible Exchangeable Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2022           $ 1 $ 422,981 $ (1,316) $ (405,727) $ 15,939
Balance (in shares) at Dec. 31, 2022     573,282     628,139        
Issue of common stock and pre-funded warrants in Securities Purchase Agreement In Registered Direct Offering, net of expenses             1,049     1,049
Issue of common stock and pre-funded warrants in Securities Purchase Agreement In Registered Direct Offering, net of expenses (in shares)           176,456        
Conversion of Preferred stock (in shares) (118,745)     39,582            
Reclassification of redeemable common stock             4,494     4,494
Reclassification of redeemable common stock (in shares)           207,806        
Stock-based compensation             1,473     1,473
Stock-based compensation (in shares)           6,909        
Preferred stock dividends             (201)     (201)
Unrealized foreign exchange on intercompany loans               12,550   12,550
Translation adjustment               (12,142)   (12,142)
Loss for the period                 (22,555) (22,555)
Balance at Dec. 31, 2023           $ 1 429,796 (908) (428,282) 607
Balance (in shares) at Dec. 31, 2023     454,537     1,058,892        
Conversion of Preferred stock (in shares) (119,000) (200,000)   39,667 3          
Issue of common stock upon conversion of pre-funded warrants in underwritten offering net of issuance costs           $ 1 6,208     6,209
Issue of common stock upon conversion of pre-funded warrants in underwritten offering net of issuance costs (in share)           706,645        
Warrant Exercises           $ 7 1,606     1,613
Warrant Exercises (in shares)           7,053,926        
Stock-based compensation             592     592
Unrealized foreign exchange on intercompany loans               (2,899)   (2,899)
Translation adjustment               2,916   2,916
Loss for the period                 (11,212) (11,212)
Balance at Dec. 31, 2024           $ 9 $ 438,202 $ (891) $ (439,494) $ (2,174)
Balance (in shares) at Dec. 31, 2024     135,537     8,859,133